Literature DB >> 19494328

Association of FcgammaRIIa (CD32a) with lipid rafts regulates ligand binding activity.

Stylianos Bournazos1, Simon P Hart, Luke H Chamberlain, Martin J Glennie, Ian Dransfield.   

Abstract

Binding of Igs to myeloid cells via FcR is a key event in the control of innate and acquired immunity. FcgammaRIIa (CD32a) is a receptor for multivalent IgG expressed predominantly by myeloid cells, and its association with microdomains rich in cholesterol and sphingolipids, termed as lipid rafts, has been reported to be essential for efficient signaling. However, for many myeloid cell types, ligand binding to CD32a is suppressed by as yet undefined mechanisms. In this study, we have examined the role of CD32a-lipid raft interactions in the regulation of IgG binding to CD32a. Disruption of lipid raft structure following depletion or sequestration of membrane cholesterol greatly inhibited CD32a-mediated IgG binding. Furthermore, specific CD32a mutants, which show reduced association with lipid rafts (A224S and C241A), displayed decreased levels of IgG binding compared with wild-type CD32a. In contrast, constitutively lipid raft-associated CD32a (GPI-anchored CD32a) exhibited increased capacity for IgG binding compared with the full-length transmembrane CD32a. Our findings clearly suggest a major role for lipid rafts in the regulation of IgG binding and, more specifically, that suppression of CD32a-mediated IgG binding in myeloid cells is achieved by receptor exclusion from lipid raft membrane microdomains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494328     DOI: 10.4049/jimmunol.0900107

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Differential requirement of lipid rafts for FcγRIIA mediated effector activities.

Authors:  Joshua A Vieth; Moo-Kyung Kim; Xiao Qing Pan; Alan D Schreiber; Randall G Worth
Journal:  Cell Immunol       Date:  2010-08-01       Impact factor: 4.868

2.  Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms.

Authors:  Kirstie L S Cleary; H T Claude Chan; Sonja James; Martin J Glennie; Mark S Cragg
Journal:  J Immunol       Date:  2017-04-12       Impact factor: 5.422

3.  Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and Fc RIIa in immune thrombocytopenia.

Authors:  Rolf T Urbanus; Dianne E van der Wal; Cornelis A Koekman; Albert Huisman; Dave J van den Heuvel; Hans C Gerritsen; Hans Deckmyn; Jan-Willem N Akkerman; Roger E G Schutgens; Eelo Gitz
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

4.  Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain.

Authors:  Andrew T Vaughan; Claude H T Chan; Christian Klein; Martin J Glennie; Stephen A Beers; Mark S Cragg
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

5.  Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils.

Authors:  Louis Marois; Guillaume Paré; Myriam Vaillancourt; Emmanuelle Rollet-Labelle; Paul H Naccache
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

6.  Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products.

Authors:  Christine W Bruggeman; Sietse Q Nagelkerke; Wendy Lau; Cedric Manlhiot; Masja de Haas; Robin van Bruggen; Brian W McCrindle; Rae S M Yeung; Taco W Kuijpers
Journal:  Blood Adv       Date:  2020-07-28

7.  Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes.

Authors:  Paul A Ramsland; William Farrugia; Tessa M Bradford; Caroline Tan Sardjono; Sandra Esparon; Halina M Trist; Maree S Powell; Peck Szee Tan; Angela C Cendron; Bruce D Wines; Andrew M Scott; P Mark Hogarth
Journal:  J Immunol       Date:  2011-08-19       Impact factor: 5.422

8.  Immune complexes and late complement proteins trigger activation of Syk tyrosine kinase in human CD4(+) T cells.

Authors:  A K Chauhan; T L Moore
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

9.  Validation of research trajectory 1 of an Exposome framework: Exposure to benzo(a)pyrene confers enhanced susceptibility to bacterial infection.

Authors:  Ryan S Clark; Samuel T Pellom; Burthia Booker; Aramandla Ramesh; Tongwen Zhang; Anil Shanker; Mark Maguire; Paul D Juarez; Matthews-Juarez Patricia; Michael A Langston; Maureen Y Lichtveld; Darryl B Hood
Journal:  Environ Res       Date:  2016-01-05       Impact factor: 6.498

10.  FcγRIIa requires lipid rafts, but not co-localization into rafts, for effector function.

Authors:  Joshua A Vieth; Moo-kyung Kim; Daniel Glaser; Kaitlyn Stiles; Alan D Schreiber; Randall G Worth
Journal:  Inflamm Res       Date:  2012-09-04       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.